ORAL ANTICOAGULANTS - MECHANISM OF ACTION, CLINICAL EFFECTIVENESS, AND OPTIMAL THERAPEUTIC RANGE

被引：87
作者：
HIRSH, J
DALEN, JE
DEYKIN, D
POLLER, L
机构：
[1] UNIV ARIZONA, COLL MED, TUCSON, AZ 85721 USA
[2] WITHINGTON HOSP, NATL REFERENCE LAB ANTICOAGULANT REAGENT & CONTROL, MANCHESTER M20 8LR, LANCS, ENGLAND
[3] VET ADM MED CTR JAMAICA PLAIN, BOSTON, MA 02130 USA
来源：
CHEST | 1992年 / 102卷 / 04期
关键词：
D O I：
10.1378/chest.102.4.312S
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：S312 / S326
页数：15
相关论文
共 132 条
[1]  
ALTMAN R, 1991, J THORAC CARDIOV SUR, V101, P427
[2]   HEREDITARY WARFARIN RESISTANCE - INVESTIGATION OF A RARE PHENOMENON [J].
ALVING, BM ;
STRICKLER, MP ;
KNIGHT, RD ;
BARR, CF ;
BERENBERG, JL ;
PECK, CC .
ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (03) :499-501
[3]  
BAILEY EL, 1971, CAN MED ASSOC J, V105, P1041
[4]  
BECHTOLD H, 1984, THROMB HAEMOSTASIS, V51, P358
[5]  
BELL RG, 1978, FED PROC, V37, P2599
[6]   VERY LOW-DOSES OF WARFARIN CAN PREVENT THROMBOSIS IN CENTRAL VENOUS CATHETERS - A RANDOMIZED PROSPECTIVE TRIAL [J].
BERN, MM ;
LOKICH, JJ ;
WALLACH, SR ;
BOTHE, A ;
BENOTTI, PN ;
ARKIN, CF ;
GRECO, FA ;
HUBERMAN, M ;
MOORE, C .
ANNALS OF INTERNAL MEDICINE, 1990, 112 (06) :423-428
[7]  
BOROWSKI M, 1986, J BIOL CHEM, V261, P4969
[8]  
BRECKENRIDGE A, 1974, CLIN PHARMACOL THER, V15, P424
[9]  
BRECKENRIDGE A, 1978, SEMIN HEMATOL, V15, P19
[10]  
BROEKMANS AW, 1983, THROMB HAEMOSTASIS, V49, P251
12345678910